However, among these variants, AR-V3/AR-V7 appears to be one of the most abundantly and ubiquitously expressed isoforms in our screening of a panel of human prostate cancer cell lines and tissues (Guo et al., 2009; Schweizer and Plymate, 2016). This evidence concerns the gene AR and prostate carcinoma.